KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • E. Van Cutsem - (Author)
  • I. Lang - (Author)
  • G. D'haens - (Author)
  • V. Moiseyenko - (Author)
  • J. Zaluski - (Author)
  • G. Folprecht - , Department of Internal Medicine I (Author)
  • S. Tejpar - (Author)
  • O. Kisker - (Author)
  • C. Stroh - (Author)
  • P. Rougier - (Author)

Details

Original languageEnglish
Number of pages1
JournalJournal of clinical oncology
Volume26
Issue number15
Publication statusPublished - 20 May 2008
Peer-reviewedYes

External IDs

ORCID /0000-0002-9321-9911/work/142252018

Keywords

Sustainable Development Goals